Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;75(3):238-245.
doi: 10.1007/s13224-025-02116-6. Epub 2025 Apr 4.

Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria

Affiliations

Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria

Okechukwu S Ogah et al. J Obstet Gynaecol India. 2025 Jun.

Abstract

Aim: The clinical profile of the disease in southern Nigeria is less reported. This study aims to describe the clinical characteristics and intra-hospital outcomes of PPCM in Ibadan, south-west Nigeria.

Materials and methods: We reviewed 69 cases of PPCM seen in Nigerian Women at the University College Hospital Ibadan between 2006 and 2021.

Results: The mean age at presentation was 30.5 ± 6.7 years (age range 18 - 46 years). The mean BMI was 23.5 kg/M2. Most were from the low socio-economic group (47/68.1%) and presented postpartum. The majority were primipara; twin pregnancy was seen in four (5.8%), and PIH occurred in 10 (14.5%) cases. Heart failure was the most typical mode of presentation. Over 90% of the women had spontaneous vertex delivery. Fetal death was recorded in three (4.3%). Two women died. Both presented with severe heart failure and died within few days on admission.

Conclusion: PPCM in Ibadan, Nigeria, is relatively a disease of primipara from poor homes and in unbooked pregnant women. Improvement in maternal health will be invaluable in prevention of the condition in Nigeria.

Keywords: Cardiomyopathy; Heart failure; Peripartum cardiomyopathy; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestAuthors declare no conflict of interest.

Similar articles

References

    1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78. 10.1093/eurjhf/hfq120. ((In eng)). - PubMed
    1. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA. 2000;283(9):1183–8. 10.1001/jama.283.9.1183. ((In eng)). - PubMed
    1. Sliwa K, Petrie MC, van der Meer P, et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):3787–97. 10.1093/eurheartj/ehaa455. - PMC - PubMed
    1. Azibani F, Sliwa K. Peripartum cardiomyopathy: an update. Curr Heart Fail Rep. 2018;15(5):297–306. 10.1007/s11897-018-0404-x. ((In eng)). - PMC - PubMed
    1. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364–70. 10.1038/nrcardio.2014.37. ((In eng)). - PubMed